Engineering a biomimetic system for hepatocyte-specific RNAi treatment of non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Engineering a biomimetic system for hepatocyte-specific RNAi treatment of non-alcoholic fatty liver disease

Published:2024-01 Issue: Volume:174 Page:281-296
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

He Xuan,Chang Zhimin,Chen Fangman,Zhang Wensheng,Sun Madi,Shi Tongfei,Liu Jie,Chen Peiyu,Zhang Kunbao,Guan Shan,Zhao Zhibin,Li Mingqiang^ORCID,Dong Wen-fei,Shao Dan^ORCID,Yang Chao

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China-Guangdong Joint Fund

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference59 articles.

1. Burden of liver diseases in the world;Asrani;J. Hepatol.,2019

2. Editorial: Chronic liver disease: new targets and new mechanisms;Ye;Front. Mol. Biosci,2022

3. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;N. Engl. J. Med.,2018

4. Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation;Schmidt;Am. J. Transplant.,2022

5. Rational design of polymeric hybrid micelles with highly tunable properties to co-deliver MicroRNA-34a and vismodegib for melanoma therapy;Li;Adv. Funct. Mater.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07

2. An Engineered Nanoplatform with Tropism Toward Irradiated Glioblastoma Augments Its Radioimmunotherapy Efficacy;Advanced Materials;2024-06-08

3. Understanding nanoparticle-liver interactions in nanomedicine;Expert Opinion on Drug Delivery;2024-06-02

4. A promising therapy for fatty liver disease: PCSK9 inhibitors;Phytomedicine;2024-06

5. Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases;Biomedicine & Pharmacotherapy;2024-06